{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:20Z","timestamp":1791860480983,"version":"4.3.4"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154680","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T13:29:27Z","timestamp":1462886967000},"page":"e0154680","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors"],"prefix":"10.1371","volume":"11","author":[{"given":"Tetsuro","family":"Yamagishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ogose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ariizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"H Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"E Tsuda","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","article-title":"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF- \u03baB in giant cell tumor of bone: possible involvement in tumour cell-induced osteoclast-like cell formation","volume":"156","author":"Haung Lin","year":"2000","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with Giant-cell tumor of bone","volume":"18","author":"DG Branstetter","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/CCO.0b013e32832c951d","article-title":"Giant cell tumor of bone","volume":"21","author":"DM Thomas","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1185\/03007995.2010.533651","article-title":"Clinical use of denosumab for the treatment for postmenoposal osteoporosis","volume":"26","author":"EM Lewiecki","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid in the treatment of bone metastases in men with castration-resistant prostate cancer: a randomized, double-blind study","volume":"377","author":"K Fizazi","year":"2011","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"A randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast cancer and prostate cancer) or multiple myeloma","volume":"29","author":"DH Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"D Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1148\/rg.331125089","article-title":"Giant cell tumor of bone: review, mimics, and new developments in treatment","volume":"33","author":"CJ Chakarun","year":"2013","journal-title":"Radiographics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trsl.2014.03.005","article-title":"Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response","volume":"164","author":"DW Pelle","year":"2014","journal-title":"Transl Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"AM Boyce","year":"2012","journal-title":"Bone Miner Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1097\/BRS.0000000000000862","article-title":"Effect of denosumab on recurrent giant cell reparative granuloma of the lumber spine","volume":"40","author":"K Akeda","year":"2015","journal-title":"Spine"},{"key":"ref14","author":"CDM Fletcher","year":"2013"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0002-9440(10)63560-2","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis","volume":"163","author":"E Grimaud","year":"2003","journal-title":"Am J Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.2106\/JBJS.M.01332","article-title":"A translational study of the neoplastic cells of giant cell tumor of bone following neoadjuvant denosumab","volume":"96","author":"IW Mak","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3171\/2014.10.SPINE13937","article-title":"Giant cell tumor of the spine: has denosumab changed the treatment paradigm?","volume":"22","author":"T Goldschlager","year":"2015","journal-title":"J Neurosurg Spine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/pbc.22720","article-title":"RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma","volume":"56","author":"JA Lee","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbo.2015.06.002","article-title":"RANK and RANK ligand expression in primary human osteosarcoma","volume":"4","author":"D Branstetter","year":"2015","journal-title":"Journal of Bone Oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:12:40Z","timestamp":1588961560000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154680"}},"subtitle":[],"editor":[{"given":"Sakamuri V.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154680","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}